Guidelines for in vivo mouse models of myocardial infarction.
暂无分享,去创建一个
M. Lindsey | C. Ripplinger | K. Brunt | R. Ritchie | J. Calvert | N. Frangogiannis | Z. Kassiri | F. Spinale | E. Thorp | K. DeLeon-Pennell | S. Frantz | L. E. de Castro Brás | R. Gumina | P. Kleinbongard | Dominic P. Del Re | Jonathan A. Kirk | Dominic P Del Re | G. Halade | S. Jones
[1] A. Engler,et al. Regenerative Crosstalk between Cardiac Cells and Macrophages. , 2021, American journal of physiology. Heart and circulatory physiology.
[2] C. Emter,et al. Large Animal Models of Heart Failure , 2020, JACC. Basic to translational science.
[3] T. Nakajima,et al. Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance. , 2020, Cardiovascular research.
[4] A. Feldman,et al. Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnover , 2020, Nature Communications.
[5] S. Houser,et al. Cortical bone derived stem-cell therapy reduces apoptosis after myocardial infarction. , 2019, American journal of physiology. Heart and circulatory physiology.
[6] Michael E. Hall,et al. Identifying the molecular and cellular signature of cardiac dilation following myocardial infarction. , 2019, Biochimica et biophysica acta. Molecular basis of disease.
[7] G. Wright,et al. Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias , 2019, Stem cell reports.
[8] J. Walsh,et al. Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac2-26, Against Myocardial Infarction , 2019, Front. Pharmacol..
[9] Amanda B. Pullen,et al. Pretreatment of carprofen impaired initiation of inflammatory‐ and overlapping resolution response and promoted cardiorenal syndrome in heart failure , 2019, Life sciences.
[10] E. Gao,et al. Resistin promotes cardiac homing of mesenchymal stem cells and functional recovery after myocardial ischemia-reperfusion via the ERK1/2-MMP-9 pathway. , 2019, American journal of physiology. Heart and circulatory physiology.
[11] F. Ginhoux,et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction , 2018, Nature Immunology.
[12] Josephine C. Adams,et al. Revised guidelines to enhance the rigor and reproducibility of research published in American Physiological Society journals. , 2018, American journal of physiology. Regulatory, integrative and comparative physiology.
[13] Guogang Zhang,et al. A minimally invasive approach to induce myocardial infarction in mice without thoracotomy , 2018, Journal of cellular and molecular medicine.
[14] M. Lindsey,et al. Mapping macrophage polarization over the myocardial infarction time continuum , 2018, Basic Research in Cardiology.
[15] M. Volpe,et al. Trehalose-Induced Activation of Autophagy Improves Cardiac Remodeling After Myocardial Infarction. , 2018, Journal of the American College of Cardiology.
[16] J. Ferreira,et al. Inclusion and exclusion criteria in research studies: definitions and why they matter , 2018, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.
[17] E. Chepurko,et al. Impact of cardiac‐specific expression of CD39 on myocardial infarct size in mice , 2017, Life sciences.
[18] P. Sexton,et al. Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice , 2017, Nature Communications.
[19] R. Graham,et al. IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction , 2016, Proceedings of the National Academy of Sciences.
[20] Courtney A Cates,et al. Temporal neutrophil polarization following myocardial infarction. , 2016, Cardiovascular research.
[21] Pallav Sengupta,et al. Men and mice: Relating their ages. , 2016, Life sciences.
[22] P. Doevendans,et al. Translational failure of anti-inflammatory compounds for myocardial infarction: a meta-analysis of large animal models. , 2016, Cardiovascular research.
[23] M. Lindsey,et al. Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying inflammation resolution. , 2015, International journal of cardiology.
[24] J. Ioannidis,et al. Reproducibility in Science: Improving the Standard for Basic and Preclinical Research , 2015, Circulation research.
[25] Eric T. Wang,et al. Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development , 2014, Nature Communications.
[26] David Handelsman,et al. Role of androgens in sex differences in cardiac damage during myocardial infarction. , 2014, Endocrinology.
[27] E. Olson,et al. Surgical models for cardiac regeneration in neonatal mice , 2014, Nature Protocols.
[28] Gregory M. Fomovsky,et al. Regional mechanics determine collagen fiber structure in healing myocardial infarcts. , 2012, Journal of molecular and cellular cardiology.
[29] C. Begley,et al. Drug development: Raise standards for preclinical cancer research , 2012, Nature.
[30] J. Zweier,et al. Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury. , 2011, Journal of molecular and cellular cardiology.
[31] F. Prinz,et al. Believe it or not: how much can we rely on published data on potential drug targets? , 2011, Nature Reviews Drug Discovery.
[32] G. Heusch,et al. The in-situ pig heart with regional ischemia/reperfusion - ready for translation. , 2011, Journal of molecular and cellular cardiology.
[33] D G Altman,et al. Improving bioscience research reporting: ARRIVE-ing at a solution , 2010, Laboratory animals.
[34] Bruce M. Psaty,et al. Minimizing bias in randomized trials: the importance of blinding. , 2010, JAMA.
[35] J. Brophy,et al. Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. , 2010, JAMA.
[36] F. Dekker,et al. Sample size calculations: basic principles and common pitfalls. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[37] R. Gu,et al. Thrombin and Its Receptor Enhance ST-Segment Elevation in Acute Myocardial Infarction by Activating the KATP Channel , 2010, Molecular medicine.
[38] L. Maia,et al. The use of lidocaine as an anti-inflammatory substance: a systematic review. , 2009, Journal of dentistry.
[39] R. Porcher,et al. Statistics in Brief: The Importance of Sample Size in the Planning and Interpretation of Medical Research , 2008, Clinical orthopaedics and related research.
[40] P. Libby,et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions , 2007, The Journal of experimental medicine.
[41] M. Entman,et al. The role of platelet-derived growth factor signaling in healing myocardial infarcts. , 2006, Journal of the American College of Cardiology.
[42] M. Harmsen,et al. Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction. , 2006, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[43] Joon Beom Seo,et al. MR imaging of reperfused myocardial infarction: comparison of necrosis-specific and intravascular contrast agents in a cat model. , 2003, Radiology.
[44] R. Kloner,et al. No-reflow phenomenon. , 2002, Circulation.
[45] D. Volker,et al. Oral buprenorphine is anti-inflammatory and modulates the pathogenesis of streptococcal cell wall polymer-induced arthritis in the Lew/SSN rat , 2000, Laboratory animals.
[46] T. McKean,et al. Comparison of the responses to hypoxia, ischaemia and ischaemic preconditioning in wild marmot and laboratory rabbit hearts. , 1996, The Journal of experimental biology.
[47] S. Kusachi,et al. Reperfusion hastens appearance and extent of distribution of type I collagen in infarct zone: immunohistochemical study in rat experimental infarction. , 1995, Cardiovascular research.
[48] M. Pfeffer,et al. Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.
[49] J. Roberts,et al. The cat as a model for myocardial infarction. , 1979, Cardiovascular research.
[50] J. Roberts,et al. Comparison of the arrhythmogenic effect of myocardial infarction in the cat and dog. , 1979, Cardiovascular research.
[51] O. Cingolani,et al. Thrombospondins in the transition from myocardial infarction to heart failure. , 2016, Journal of molecular and cellular cardiology.
[52] R. Gourdie,et al. Cryoinjury models of the adult and neonatal mouse heart for studies of scarring and regeneration. , 2013, Methods in molecular biology.
[53] E. Thorp,et al. Quantitation of acute necrosis after experimental myocardial infarction. , 2013, Methods in molecular biology.
[54] M. Lindsey,et al. Cardiac wound healing post-myocardial infarction: a novel method to target extracellular matrix remodeling in the left ventricle. , 2013, Methods in molecular biology.
[55] M. Ruiz-Meana,et al. Animal ethics in Cardiovascular Research. , 2012, Cardiovascular research.
[56] M. Harmsen,et al. Cryoinjury: a model of myocardial regeneration. , 2008, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[57] K. Murray,et al. Phenotyping of genetically engineered mice: humane, ethical, environmental, and husbandry issues. , 2006, ILAR journal.